TürkiyeDiagnosis and screening
Broad genetic testing in inherited nerve disease: cause found in three quarters of 63 families in Istanbul
Koç University studied 67 people with suspected CMT.
Neuromuscular diseases
A group of inherited diseases that affect the nerves in the arms and legs. It causes weakness and loss of feeling in the feet, legs and hands. It progresses slowly.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
This page is translated from the Turkish original.
This disease is followed through the “Neuromuscular diseases” group.
The nerves outside the brain and spinal cord, called peripheral nerves, are damaged. These nerves carry commands to the muscles and carry senses such as touch to the brain. In the disease, the covering of the nerve or the nerve fiber itself breaks down. Because the longest nerves are affected first, symptoms begin in the feet.
Symptoms often begin between the ages of 5 and 15. Severity varies greatly from person to person.
The doctor examines muscle strength, reflexes and feeling. Nerve conduction tests help tell the type of the disease. A genetic test can be done for most types.
There is not yet an approved treatment specific to the disease; research is ongoing. Physiotherapy and suitable exercise help maintain muscle strength. Occupational therapy makes daily tasks easier. Orthoses, special shoes and walking aids make walking easier. Surgery may be needed for foot deformities. Areas with loss of feeling are protected from injury. The doctor who follows the disease decides which treatment is suitable.
The pattern of inheritance depends on the type. The most common types are passed on through dominant inheritance; for each child of an affected parent, the chance is 1 in 2. Some types are passed on through recessive inheritance; for a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. In the X-linked type, males are usually more severely affected. In about 10% of cases, the change does not come from the family. Genetic counselling helps the family understand the risk.
Source: MedlinePlus Genetics: Charcot-Marie-Tooth disease · NHS: Charcot-Marie-Tooth disease · MedlinePlus Medical Encyclopedia: Charcot-Marie-Tooth disease
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
For all rare diseases: Nadir Hastalıklar Federasyonu
Links checked on October 8, 2026.
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
TürkiyeDiagnosis and screening
Koç University studied 67 people with suspected CMT.
TürkiyeResearch and clinical trials
In Istanbul, 311 CMT patients from 265 families were studied.
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
Questions you can ask your doctor
ClinicalTrials.gov lists 19 active interventional studies for this disease. 14 are recruiting now; none has a site in Türkiye. Last checked: October 7, 2026.
Selected records (studies with a site in Türkiye first):
Middle stage: the effect is being tested in a small group · Phase 1 / Phase 2 · investigational (experimental)RecruitingNCT07447557
Early stage: safety and dose are being tested · Phase 1 · investigational (experimental)RecruitingNCT07140614
Middle stage: the effect is being tested in a small group · Phase 1 / Phase 2 · investigational (experimental)RecruitingNCT06328712
Middle stage: the effect is being tested in a small group · Phase 1 / Phase 2 · investigational (experimental)Active, not recruitingNCT07223632
Middle stage: the effect is being tested in a small group · Phase 1 / Phase 2 · investigational (experimental)Enrolling by invitationNCT07226297
See all studies on ClinicalTrials.gov · Joining clinical trials
InternationalResearch and clinical trials
The HIMALAYA study, published in The Lancet Neurology, examined an experimental drug in patients with ALS (amyotrophic lateral sclerosis).
TürkiyeResearch and clinical trials
A multicenter study in Istanbul compared patients with Guillain-Barré syndrome.
USANew treatments and approvals
The US Food and Drug Administration (FDA) approved levacetylleucine for balance and walking problems in ataxia-telangiectasia (A-T).
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:166 · ICD-11 8C20
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.